Evidence map›Paper›PMID 27592001›Full record

ArticleArchives of toxicology2017

Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity.

Salil N Pendse, Alexandra Maertens, Michael Rosenberg, Dipanwita Roy, Rick A Fasani, Marguerite M Vantangoli, Samantha J Madnick, Kim Boekelheide, Albert J Fornace, Shelly-Ann Odwin and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Archives of toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Salil N PendseThe Hamner Institutes for Health Sciences, Research Triangle Park, NC, USA.
Alexandra MaertensCenter for Alternatives to Animal Testing (CAAT), Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Michael RosenbergAgilent Technologies, Inc., Santa Clara, CA, USA.
Dipanwita RoyAgilent Technologies, Inc., Santa Clara, CA, USA.
Rick A FasaniAgilent Technologies, Inc., Santa Clara, CA, USA.
Marguerite M VantangoliDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Samantha J MadnickDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Kim BoekelheideDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Albert J FornaceDepartment of Biochemistry and Molecular and Cellular Biology, and Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Shelly-Ann OdwinDepartment of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
James D YagerDepartment of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Thomas HartungCenter for Alternatives to Animal Testing (CAAT), Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Melvin E AndersenThe Hamner Institutes for Health Sciences, Research Triangle Park, NC, USA.
Patrick D McMullenThe Hamner Institutes for Health Sciences, Research Triangle Park, NC, USA. pmcmullen@scitovation.com.
Agilent Technologies (United States) · USBrown University · USJohns Hopkins University · USThe Hamner Institutes for Health Sciences · USGeorgetown University Medical Center · USUniversity of Konstanz · DE

Funding

Mapping the Human Toxome by Systems ToxicologyR01ES020750 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI HARTUNG, THOMAS · 2011 to 2015
$6.0M
NIEHS NIH HHS R01 ES020750
6 · The paper itself

Abstract

The twenty-first century vision for toxicology involves a transition away from high-dose animal studies to in vitro and computational models (NRC in Toxicity testing in the 21st century: a vision and a strategy, The National Academies Press, Washington, DC, 2007). This transition requires mapping pathways of toxicity by understanding how in vitro systems respond to chemical perturbation. Uncovering transcription factors/signaling networks responsible for gene expression patterns is essential for defining pathways of toxicity, and ultimately, for determining the chemical modes of action through which a toxicant acts. Traditionally, transcription factor identification is achieved via chromatin immunoprecipitation studies and summarized by calculating which transcription factors are statistically associated with up- and downregulated genes. These lists are commonly determined via statistical or fold-change cutoffs, a procedure that is sensitive to statistical power and may not be as useful for determining transcription factor associations. To move away from an arbitrary statistical or fold-change-based cutoff, we developed, in the context of the Mapping the Human Toxome project, an enrichment paradigm called information-dependent enrichment analysis (IDEA) to guide identification of the transcription factor network. We used a test case of activation in MCF-7 cells by 17β estradiol (E2). Using this new approach, we established a time course for transcriptional and functional responses to E2. ERα and ERβ were associated with short-term transcriptional changes in response to E2. Sustained exposure led to recruitment of additional transcription factors and alteration of cell cycle machinery. TFAP2C and SOX2 were the transcription factors most highly correlated with dose. E2F7, E2F1, and Foxm1, which are involved in cell proliferation, were enriched only at 24 h. IDEA should be useful for identifying candidate pathways of toxicity. IDEA outperforms gene set enrichment analysis (GSEA) and provides similar results to weighted gene correlation network analysis, a platform that helps to identify genes not annotated to pathways.

Indexed as

AnimalsCell ProliferationEstradiolEstrogen Receptor alphaEstrogen Receptor betaGene Expression RegulationHumansMCF-7 CellsSignal TransductionSOXB1 Transcription FactorsTime FactorsToxicity TestsTranscription Factor AP-2Transcription FactorsESR1 protein, humanEstradiolEstrogen Receptor alphaEstrogen Receptor betaSOX2 protein, humanSOXB1 Transcription FactorsTFAP2C protein, humanTranscription Factor AP-2Transcription FactorsBioinformaticsEndocrine DisruptionEnrichment AnalysisGene ExpressionPathways of Toxicity

Identifiers

PMID27592001
PMCPMC5364265
OpenAlexW2517298271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.